Last reviewed · How we verify
A Novel Nano-iron Supplement to Safely Combat Iron Deficiency and Anaemia in Young Children: a Doubleblind Randomised Controlled Trial (IHAT-Gut)
This study aims to determine whether IHAT is non-inferior to ferrous sulphate at correcting iron deficiency and anaemia, and if IHAT does not increase diarrhoea risk in young children living in rural and resource-poor areas of the Gambia. The study hypothesis is that IHAT will eliminate iron deficiency and improve haemoglobin levels in young children without increasing infectious diarrhoea or promoting inflammation in the gut.
Details
| Lead sponsor | London School of Hygiene and Tropical Medicine |
|---|---|
| Phase | PHASE2 |
| Status | COMPLETED |
| Enrolment | 645 |
| Start date | Mon Jan 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Iron Deficiency, Anaemia in Children
Interventions
- IHAT
- Ferrous Sulphate
- Placebo
Countries
The Gambia